Enrolling adolescents in HIV vaccine trials: reflections on legal complexities from South Africa
| dc.contributor.author | Slack, Catherine | en_ZA |
| dc.contributor.author | Strode, Ann | en_ZA |
| dc.contributor.author | Fleischer, Theodore | en_ZA |
| dc.contributor.author | Gray, Glenda | en_ZA |
| dc.contributor.author | Ranchod, Chitra | en_ZA |
| dc.date.accessioned | 2015-10-12T10:47:45Z | |
| dc.date.available | 2015-10-12T10:47:45Z | |
| dc.date.issued | 2007 | en_ZA |
| dc.description.abstract | BACKGROUND:South Africa is likely to be the first country in the world to host an adolescent HIV vaccine trial. Adolescents may be enrolled in late 2007. In the development and review of adolescent HIV vaccine trial protocols there are many complexities to consider, and much work to be done if these important trials are to become a reality.DISCUSSION:This article sets out essential requirements for the lawful conduct of adolescent research in South Africa including compliance with consent requirements, child protection laws, and processes for the ethical and regulatory approval of research.SUMMARY:This article outlines likely complexities for researchers and research ethics committees, including determining that trial interventions meet current risk standards for child research. Explicit recommendations are made for role-players in other jurisdictions who may also be planning such trials. This article concludes with concrete steps for implementing these important trials in South Africa and other jurisdictions, including planning for consent processes; delineating privacy rights; compiling information necessary for ethics committees to assess risks to child participants; training trial site staff to recognize when disclosures trig mandatory reporting response; networking among relevant ethics commitees; and lobbying the National Regulatory Authority for guidance. | en_ZA |
| dc.identifier.apacitation | Slack, C., Strode, A., Fleischer, T., Gray, G., & Ranchod, C. (2007). Enrolling adolescents in HIV vaccine trials: reflections on legal complexities from South Africa. <i>BMC Medical Ethics</i>, http://hdl.handle.net/11427/14160 | en_ZA |
| dc.identifier.chicagocitation | Slack, Catherine, Ann Strode, Theodore Fleischer, Glenda Gray, and Chitra Ranchod "Enrolling adolescents in HIV vaccine trials: reflections on legal complexities from South Africa." <i>BMC Medical Ethics</i> (2007) http://hdl.handle.net/11427/14160 | en_ZA |
| dc.identifier.citation | Slack, C., Strode, A., Fleischer, T., Gray, G., & Ranchod, C. (2007). Enrolling adolescents in HIV vaccine trials: reflections on legal complexities from South Africa. BMC Medical Ethics, 8(1), 5. | en_ZA |
| dc.identifier.ris | TY - Journal Article AU - Slack, Catherine AU - Strode, Ann AU - Fleischer, Theodore AU - Gray, Glenda AU - Ranchod, Chitra AB - BACKGROUND:South Africa is likely to be the first country in the world to host an adolescent HIV vaccine trial. Adolescents may be enrolled in late 2007. In the development and review of adolescent HIV vaccine trial protocols there are many complexities to consider, and much work to be done if these important trials are to become a reality.DISCUSSION:This article sets out essential requirements for the lawful conduct of adolescent research in South Africa including compliance with consent requirements, child protection laws, and processes for the ethical and regulatory approval of research.SUMMARY:This article outlines likely complexities for researchers and research ethics committees, including determining that trial interventions meet current risk standards for child research. Explicit recommendations are made for role-players in other jurisdictions who may also be planning such trials. This article concludes with concrete steps for implementing these important trials in South Africa and other jurisdictions, including planning for consent processes; delineating privacy rights; compiling information necessary for ethics committees to assess risks to child participants; training trial site staff to recognize when disclosures trig mandatory reporting response; networking among relevant ethics commitees; and lobbying the National Regulatory Authority for guidance. DA - 2007 DB - OpenUCT DP - University of Cape Town J1 - BMC Medical Ethics LK - https://open.uct.ac.za PB - University of Cape Town PY - 2007 T1 - Enrolling adolescents in HIV vaccine trials: reflections on legal complexities from South Africa TI - Enrolling adolescents in HIV vaccine trials: reflections on legal complexities from South Africa UR - http://hdl.handle.net/11427/14160 ER - | en_ZA |
| dc.identifier.uri | 10.1186/1472-6939-8-5 | en_ZA |
| dc.identifier.uri | http://hdl.handle.net/11427/14160 | |
| dc.identifier.vancouvercitation | Slack C, Strode A, Fleischer T, Gray G, Ranchod C. Enrolling adolescents in HIV vaccine trials: reflections on legal complexities from South Africa. BMC Medical Ethics. 2007; http://hdl.handle.net/11427/14160. | en_ZA |
| dc.language.iso | eng | en_ZA |
| dc.publisher | BioMed Central Ltd | en_ZA |
| dc.publisher.department | Centre for Bioethics | en_ZA |
| dc.publisher.faculty | Faculty of Health Sciences | en_ZA |
| dc.publisher.institution | University of Cape Town | |
| dc.rights | This is an Open Access article distributed under the terms of the Creative Commons Attribution License | en_ZA |
| dc.rights.uri | http://creativecommons.org/licenses/by/2.0 | en_ZA |
| dc.source | BMC Medical Ethics | en_ZA |
| dc.source.uri | http://www.biomedcentral.com/bmcmedethics/ | en_ZA |
| dc.subject.other | HIV | en_ZA |
| dc.subject.other | Vaccine trials | en_ZA |
| dc.subject.other | Ethics | en_ZA |
| dc.title | Enrolling adolescents in HIV vaccine trials: reflections on legal complexities from South Africa | en_ZA |
| dc.type | Journal Article | en_ZA |
| uct.type.filetype | Text | |
| uct.type.filetype | Image | |
| uct.type.publication | Research | en_ZA |
| uct.type.resource | Article | en_ZA |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Slack_adolescents_in_HIV_vaccine_trials_2007.pdf
- Size:
- 283.04 KB
- Format:
- Adobe Portable Document Format
- Description: